When to Start Unfractionated Heparin After LMWH
You can start unfractionated heparin (UFH) infusion immediately after the last dose of low-molecular-weight heparin (LMWH) without any mandatory waiting period, particularly if urgent cardiac catheterization or PCI is planned. 1
Rationale and Clinical Approach
The 2014 AHA/ACC guidelines for NSTE-ACS explicitly list both enoxaparin (LMWH) and UFH as acceptable Class I anticoagulation options, and switching between them is a recognized clinical scenario 1. The key consideration is not timing, but bleeding risk.
Immediate Transition Strategy
- No washout period is required between LMWH and UFH
- Start UFH infusion with standard dosing: 60 IU/kg bolus (maximum 4000 IU) followed by 12 IU/kg/hour infusion (maximum 1000 IU/hour) 2
- Adjust infusion to maintain aPTT 1.5-2 times control (or 50-70 seconds) 1
- Check aPTT approximately 4 hours after starting infusion, then at appropriate intervals 2
Critical Caveat: The SYNERGY Bleeding Risk
The most important pitfall to avoid is "stacking" anticoagulants. The SYNERGY trial demonstrated increased TIMI major bleeding when patients received both enoxaparin and additional UFH, particularly around the time of PCI 1. This bleeding was attributed to overlapping anticoagulant effects, not the transition itself.
Practical Algorithm
If proceeding to immediate catheterization/PCI:
- Start UFH infusion now without delay
- The residual anti-Xa activity from LMWH (0.4 mL enoxaparin = ~40 mg) will overlap with UFH for several hours
- Accept this overlap as clinically necessary, but monitor closely for bleeding
If catheterization is delayed (>8-12 hours):
- You can still start UFH immediately
- By the time of intervention, most LMWH effect will have dissipated (enoxaparin half-life ~4-5 hours)
- This reduces bleeding risk from overlapping anticoagulation
Monitoring Strategy
- Baseline: aPTT, INR, platelet count, hemoglobin 2
- aPTT at 4 hours after UFH initiation, then every 4-6 hours until stable 2
- Daily CBC to monitor for bleeding or heparin-induced thrombocytopenia
- Watch for signs of hemorrhage: unexplained hypotension, hematocrit drop, occult blood 2
The evidence does not support delaying UFH infusion after LMWH. The guidelines treat these as interchangeable options for continuous anticoagulation in unstable angina 1. Clinical trials like FRIC directly compared LMWH to UFH with similar efficacy and safety profiles 3, confirming that transitioning between them is appropriate when clinically indicated.